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FIGURE 2 CT Evaluation Pre-Implant, Benchtop Evaluation and Follow-Up CT
(A) Multislice computed tomography (CT) evaluation: a diameter of 32.9  20 mm and a perimeter-derived diameter of 27.4 mm at the center of the surgical annu-
loplasty ring. (B) Aortomitral annular angle of 121 suggesting a low risk of left ventricular outlet tract (LVOT) obstruction from mitral valve implantation. (C) Simulation
of DFM dimensions showing that LVOT obstruction would be unlikely with the valve placed only 4 mm into the left ventricle. (D,E) Benchtop image of a 29-mm DFM
implanted in a 34-mm Seguin ring (arrows) in same position as patient. (F to I) Follow-up CT images at 9 month showing stable valve position that is not interfering with
LVOT (F); axial CT images (Online Video 2) of the DFM valve (as shown in E at the level of the D-shaped ventricular ring conforming to the shape of the surgical ring (G),
at the leaﬂets showing good coaptation (H), and at the circular atrial ring (I).
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e106a feasible alternative in selected high-risk patients
and associated with good short-term outcomes (1).
However, there are still numerous procedural chal-
lenges that can occur such as device malpositioning,
valve stability and anchoring, paravalvular leak, and
left ventricular outﬂow tract (LVOT) obstruction. Un-
til now, only balloon-expandable valves have been
used for this indication with the limitation that this
is a one-shot procedure. We report the ﬁrst-in-
human implantation of a fully repositionable and
retrievable transcatheter valve in the mitral position.
A 76-year-old woman with chronic atrial ﬁbrillation
presented with recurrent episodes of heart failure.She had previously undergone surgical mitral valve
repair (edge-to-edge plus annuloplasty with a St. Jude
Seguin 34-mm ring) and coronary artery bypass
grafting (left internal mammary artery to left anterior
descending artery and a saphenous vein graft to the
ﬁrst diagonal). Echocardiography demonstrated
severe central MR without evidence of the previous
edge-to-edge repair (Figures 1A to 1C) and an ejection
fraction of 34%. Multislice computed tomography
(MSCT) demonstrated a perimeter-derived diameter
of 27.4 mm (Figures 2A to 2C) compatible with a
29-mm prosthesis. Our multidisciplinary heart team
agreed that a transcatheter procedure was indicated.
FIGURE 3 Fluoroscopic Imaging of Procedure
Fluoroscopic images summarizing procedural steps. (A) Baseline ventriculography demonstrating the mitral annular level as the annuloplasty ring is not radiographically
visible (Online Video 3). (B) The DFM valve delivered via transapical access is unsheathed in the left ventricle. (C) The valve is positioned with only the distal ring inﬂated.
(D) The proximal ring is then inﬂated when positioned on the ventricular aspect of the annulus with both rings parallel to the mitral annulus (Online Video 4).
(E) Ventriculography conﬁrming the correct position of valve and the absence of mitral regurgitation. (F) Final appearance of the DFM valve in the mitral position
(Online Video 5).
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e107In view of the radiolucent semirigid mitral ring that
could potentially make accurate positioning chal-
lenging, implantation with a fully retrievable and
repositionable valve was deemed to be advantageous
with the option to reposition or fully retrieve the
valve if the result was suboptimal.
The procedure was performed with the patient
under general anesthesia in a hybrid operating room
with standard transapical access (Figure 3, Online
Videos 3, 4, and 5). After crossing the mitral valve
and placing a stiff wire in the right inferior pulmo-
nary vein, a 22-F sheath was inserted into the left
ventricle (LV). The Direct Flow Medical (DFM) trans-
catheter valve system (Direct Flow Medical Inc., Santa
Rosa, California) was inserted in the left atrium, the
valve was unsheathed, and the non-metallic double
ring valve was inﬂated in the left atrium. Theventricular ring was deﬂated, and the prosthesis
pulled toward the LV until the ventricular ring was
within the LV and the inﬂated atrial ring was parallel
to the mitral annulus. Inﬂation of the ventricular
ring conﬁrmed symmetrical expansion and sealing
with no residual MR on ventriculography. The valve
was deliberately positioned more atrially to take
advantage of the larger 31-mm proximal ring for
sealing and to prevent LVOT obstruction. During
valve positioning, the patient was stable because
there was a functional valve across the native mitral
valve. Transesophageal echocardiography conﬁrmed
the absence of central and paravalvular MR, a mean
transprosthetic gradient of 2 mm Hg and no evi-
dence of LVOT obstruction (Figures 1D to 1F, Online
Video 1). The valve was ﬁxed in position by the
polymer exchange and detached as previously
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e108described (2). The patient was discharged on day 5. At
9-month follow-up, she was asymptomatic (New York
Heart Association functional class I) with no residual
paravalvular leak, a stable transprosthetic gradient
of 4 mm Hg, and stable valve position conﬁrmed by
MSCT (Figures 2F to 2I, Online Video 2).
This is the ﬁrst-ever case of a nonballoon-
expandable valve being implanted in the mitral
position. The principal advantage of having a
fully repositionable and retrievable valve is that it
allowed for the treatment of a radiolucent annulo-
plasty ring in a controlled and safe manner. The
non-metallic conformable structure and rings of theDFM valve may be particularly advantageous in the
mitral position to ensure sealing of the D-shaped
annulus, with excellent hemodynamics, as evidenced
by the follow-up computed tomography. This case is
sufﬁciently encouraging to warrant further evalua-
tion of the DFM valve for transcatheter mitral valve-
in-ring implantation.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
Azeem Latib, EMO-GVM Centro Cuore Columbus,
Via Buonarroti 48, 20145 Milan. E-mail: info@
emocolumbus.it.RE F E RENCE S1. Descoutures F, Himbert D, Maisano F, et al.
Transcatheter valve-in-ring implantation after
failure of surgical mitral repair. Eur J Cardiothorac
Surg 2013;44:e8–15.
2. Schofer J, Colombo A, Klugmann S, et al. Pro-
spective multicenter evaluation of the Direct Flow
Medical transcatheter aortic valve. J Am Coll
Cardiol 2014;63:763–8.KEY WORDS direct ﬂow valve, mitral valve,
transcatheter valve implantation, valve-in-
ring, valve-in-valveAPPENDIX For accompanying videos and
their legends, please see the online version of
this article.
